Economic crisis: bane or boon for emarketing?

It took a while before pharma started to embrace the digital world as a (future) component of its go-to-market strategy, but in 2008, many companies finally started to get high-visibility strategic pr

By Anonymous (not verified) on Jan 17, 2009

It took a while before pharma started to embrace the digital world as a (future) component of its go-to-market strategy, but in 2008, many companies finally started to get high-visibility strategic projects underway.

This trend was not only driven by the increasing customer preference for online resources, but also by the pressing need for pharma to change its commercial model.

However, 2009 is proving to be a very difficult year for the economy at large, and also for pharma. The key question then becomes: Will the crisis have a positive impact on spending in the digital space ("Kill your darlings") or will it lead to a more risk-averse approach ("Stick with your darlings")?

Across Health is running a short survey to gauge the key trends in this space. Are pharma decision makers investing in the digital space? If so, what are they investing in? More/less than in the past? What is the organizational model? What are the key barriers? etc etc.

The results of the survey will be made available to all participants and I will also share some thoughts on my blog.

So, what are you waiting for? Click here to take the 10-minute survey

The wisdom of crowds applies here as well: the more responses we get, the more reliable the results will be.

Thanks!!

Fonny
Managing Director, Across Health

PS the survey is only intended for decision makers employed by pharma companies.